热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-human CD45 Antibody
产品名称：
FITC anti-human CD45 Antibody
产品类别：
抗体
产品编号：
304005
产品应用：
304005
[价格]
规格 价格 库存
25tests ￥ 396 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
?g size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
?g sizes: 0.5 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The CD45 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the ?g size, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections and formalin-fixed paraffin-embedded tissue sections9, inhibition of CD45 functions4, immunofluorescence11,?Western blotting3, and spatial biology (IBEX)16,17.

It was found that the HI30 clone and the 2D1 clone can cross block each other's binding.

Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Kishihara K, et al. 1993. Cell 74:143.
  3. Esser M, et al. 2001. J. Virol. 75:6173. (WB)
  4. Yamada T, et al. 2002. J. Biol. Chem. 277:28830.
  5. Nagano M, et al. 2007. Blood 110:151.
  6. Jiang Q, et al. 2008. Blood 112:2858. PubMed
  7. Morozov A, et al. 2010. Clin Cancer Res. 16:5630. PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Friedman T, et al. 1999. J. Immunol. 162:5256. (IHC)
  10. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. (FC) PubMed
  11. Rees LE, et al. 2003. Clin. Exp. Immunol. 134:497. (IF)
  12. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
  13. Breton G, et al. 2015. J Exp Med. 212:401. PubMed
  14. Marquardt N, et al. 2015. J Immunol. 6:2467. PubMed
  15. Bushway ME, et al. 2014. Biol Reprod. 90(5): 110. (IF) PubMed
  16. Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
  17. Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
Product Citations
  1. Mulay A, et al. 2021. Cell Reports. 35(5):109055. PubMed
  2. Li Q, et al. 2019. Am J Transl Res. 10:4322. PubMed
  3. Chabi S, et al. 2020. Cell Reports. 29(8):2307-2320.e6.. PubMed
  4. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  5. Ducoli L, et al. 2021. Nat Commun. 12:925. PubMed
  6. Chen X, et al. 2022. Front Bioeng Biotechnol. 10:915181. PubMed
  7. Zong D, et al. 2021. BMC Biol. 19:79. PubMed
  8. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  9. Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed
  10. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  11. Gomzikova MO, et al. 2019. Cells. 0.440972222. PubMed
  12. Selich A, et al. 2019. Stem Cell Reports. 13:262. PubMed
  13. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  14. Sun Z, et al. 2022. Stem Cell Res Ther. 13:297. PubMed
  15. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  16. Travaglini KJ, et al. 2020. Nature. 587:619. PubMed
  17. Grove K, et al. 2016. PLoS One. 11: 0145961. PubMed
  18. Skrbo N, et al. 2014. PLoS One. 9:113278. PubMed
  19. Wang D, et al. 2019. Cell Res. 29:832. PubMed
  20. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  21. Liu Z, et al. 2021. Molecules. 26:. PubMed
  22. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  23. Xia Y, et al. 2019. Gastroenterol Res Pract. 2019:5436961. PubMed
  24. Schulz A, et al. 2019. Cell Rep. 29:1074. PubMed
  25. Baccelli I, et al. 2020. Cancer Cell. 36(1):84-99. PubMed
  26. Chen P, et al. 2021. Front Immunol. 12:689019. PubMed
  27. Evans RDR, et al. 2020. Nat Commun. 3.491666667. PubMed
  28. Koide M, et al. 2018. Tohoku J Exp Med. 244:15:00. PubMed
  29. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  30. Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed
  31. Yan K, et al. 2022. iScience. 25:104822. PubMed
  32. Song M, et al. 2022. J Gene Med. 24:e3455. PubMed
  33. Ehlers L, et al. 2021. The FASEB Journal. 35(7):e21684. PubMed
  34. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. PubMed
  35. Wu L, et al. 2018. Oncol Lett. 15:9507. PubMed
  36. Yan Y, et al. 2018. JCI Insight. 3. PubMed
  37. Zhang B, et al. 2013. PLoS One. 8:57114. PubMed
  38. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  39. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  40. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  41. Pabst C, et al. 2016. Blood. 127: 2018-2027. PubMed
  42. Wang L, et al. 2014. Proc Natl Acad Sci U S A. 111:3146. PubMed
  43. Ronaldson-Bouchard K, et al. 2022. Nat Biomed Eng. 6:351. PubMed
  44. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  45. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  46. van Gastel N, et al. 2020. Cell Metabolism. 32(3):391-403.e6. PubMed
  47. Joly P, et al. 2017. PLoS One. 12(6):e0180568. PubMed
  48. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
  49. Lee HJ, et al. 2017. Oncotarget. 8:113345. PubMed
  50. Dai Z, et al. 2022. Signal Transduct Target Ther. 7:85. PubMed
  51. Sicklinger F, et al. 2021. J Clin Invest. 131:. PubMed
  52. Okurut S, et al. 2020. Infect Immun. 88:. PubMed
  53. Hsieh J, et al. 2013. Nucleic Acids Res. 41:9753. PubMed
  54. Didigu C, et al. 2014. Blood. 123:61. PubMed
  55. Saraiva L, et al. 2019. Cytometry B Clin Cytom. N/A. PubMed
  56. Nano R, et al. 2022. STAR Protoc. 3:101354. PubMed
  57. Xu L, et al. 2022. Int J Mol Sci. 23:. PubMed
  58. Blomme EE, et al. 2021. Clin Transl Immunology. 10:e1287. PubMed
  59. He Y, et al. 2022. Cells. 11:. PubMed
  60. Garrido-Martin EM, et al. 2020. J Immunother Cancer. 8:00. PubMed
  61. Ran Y, et al. 2022. Stem Cell Res Ther. 13:507. PubMed
  62. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  63. Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
  64. S Tzeng 2016. J Vis Exp. 118:e54582. PubMed
  65. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  66. Vishnoi M, et al. 2019. Mol Oncol. 13(9): 1913. PubMed
  67. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  68. Zamarin D, et al. 2020. Clin Cancer Res. 26:4531. PubMed
  69. Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed
  70. Genbacev O, et al. 2016. Hum Reprod. 31: 1300 - 1314. PubMed
  71. Rousset F, et al. 2018. Mol Ther Nucleic Acids. 14:351. PubMed
  72. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  73. Wu SZ, et al. 2020. EMBO J. 39:e104063. PubMed
  74. Bailey AL, et al. 2020. bioRxiv. . PubMed
  75. Haynes BA, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2168. PubMed
  76. Tomellini E, et al. 2020. Cell Reports. 28(4):1063-1073.e5.. PubMed
  77. Sprouse ML, et al. 2019. Int J Mol Sci. 20:8. PubMed
  78. Niu C, et al. 2017. Mol Med Rep. 16:4879. PubMed
  79. Sun YF, et al. 2021. Nat Commun. 12:4091. PubMed
RRID
AB_314393 (BioLegend Cat. No. 304005) AB_314394 (BioLegend Cat. No. 304006) AB_2564154 (BioLegend Cat. No. 304054) AB_2562050 (BioLegend Cat. No. 304038)

Antigen Details

Structure
Tyrosine phosphatases, type I transmembrane protein, 180-240 kD (multiple isoforms)
Distribution

Hematopoietic cells, not expressed in circulating erythrocytes or platelets

Function
TCR and BCR mediated activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
Hematopoietic stem and progenitors, Mesenchymal Stem Cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References
  1. Thomas M. 1989. Annu. Rev. Immunol. 7:339.
  2. Trowbridge I, et al. 1994. Annu. Rev. Immunol.12:85.
Gene ID
5788 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线